CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,939
- in 3 filings, $45K under 10b5-1 plans
Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Davis Todd C Director | Purchase | +35,445 | $27.80 | $986K | 75,331 |
| 2026-06-11 | Davis Todd C Director | Purchase | +503 | $28.73 | $14K | 75,834 |
| 2024-09-13 | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Purchase | +3,500 | $0.97 | $3K | 547,710 |
| 2024-09-12 | Malamut Richard Director | Purchase | +10,400 | $0.94 | $10K | 91,565 |
| 2024-09-12 | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Purchase | +1,700 | $0.97 | $2K | 544,210 |
| 2024-09-11 | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Purchase | +5,500 | $0.94 | $5K | 542,510 |
| 2024-09-10 | Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Purchase | +6,500 | $0.89 | $6K | 537,010 |
| 2024-02-21 | Friedberg Ezra M Director | Purchase | +16,667 | $6.00 | $100K | 545,721 |
Page 1 of 1 · 8 trades